Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway
Abstract Background Diabetic nephropathy (DN) is the leading cause of end-stage renal failure, contributing to severe morbidity and mortality in diabetic patients. Berberine (BBR) has been well characterized to exert renoprotective effects in DN progression. However, the action mechanism of BBR in D...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-03-01
|
Series: | Biological Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40659-018-0157-8 |